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In the paper, the results of the first regular studies of ultra-small iron oxide nanoparticles (IONPs) 
toxicity in vitro were presented. The influence of PEG-coated NPs with 5 nm magnetite core on six 
different cell lines was examined. These were: human bronchial fibroblasts, human embryonic kidney 
cells (HEK293T), two glioblastoma multiforme (GBM) cell lines as well as GBM cells isolated from a 
brain tumor of patient. Additionally, mouse macrophages were included in the study. The influence 
of IONPs in three different doses (1, 5 and 25 µg Fe/ml) on the viability, proliferation and migration 
activity of cells was assessed. Moreover, quantifying the intracellular ROS production, we determined 
the level of oxidative stress in cells exposed to IONPs. In the paper, for the first time, the effect of Fe in 
the form of IONPs was compared with the analogical data obtained for iron salts solutions containing 
the same amount of Fe, on the similar oxidation state. Our results clearly showed that the influence 
of iron on the living cells strongly depends not only on the used cell line, dose and exposure time but 
also on the form in which this element was administered to the culture. Notably, nanoparticles can 
stimulate the proliferation of some cell lines, including glioblastoma multiforme. Compared to Fe 
salts, they have a stronger negative impact on the viability of the cells tested. Ultra-small NPs, also, 
more often positively affect cell motility which seem to differ them from the NPs with larger core 
diameters.
Increasing interest in the application of superparamagnetic iron oxide nanoparticles (IONPs) in various fi lds 
of biomedicine, including cancer diagnostics and therapy, entails the necessity of their toxicological profile 
 assessment1,2. A fi st approach to such study falls at the turn of 80s and 90s of the last century when IONPs 
were introduced to clinics as contrast  agents3,4. Despite the passage of time, the potentially damaging effects of 
IONPs still rise a lot of controversies and the adverse effects of both intended and unintended exposure to the 
nanoparticles (NPs) are still a subject of many scientifi   research5–7.
The in vitro studies constitutes basic method for the assessment of the toxicity and biocompatibility of NPs 
and other nanomaterials (NMs)8. Among their advantages little costs, low complexity of the examined system, 
short time of the experiment and minimal ethical issues can be  included8,9. The in vitro assays provide the 
information on cells life parameters such as viability, proliferation rate, motility or metabolic activity, which are 
commonly used in the toxicity  assessment9. Their great advantage is also a possibility to control and reproduce 
experimental conditions, which signifi antly increase the repeatability of the obtained results as well as analysis 
of the biocompatibility and tolerance of higher NPs  doses10–14. It should be mentioned that in vitro investiga-
tions cannot completely replace animal based experiments, but can limit them to the situations when the use of 
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animals is necessary. Moreover, in vitro studies provide valuable mechanistic information on the NPs toxicity 
after investigation carried in in vivo  conditions15.
Vakili-Ghartavol et al., and Patil et al., summarized published till now results of the in vitro investigations 
concerning the toxicity of IONPs, comparing the effects of NPs with different physicochemical properties on 
various cell lines. In the light of their studies as well as other existing literature, the toxicity of IONPs strongly 
depends on NPs size, surface coating, dose and the type of cells exposed to their  action10,11,16,17.
In this paper, the influence of ultra-small IONPs with 5 nm magnetite core and PEG coating (NPs hydro-
dynamic diameter equal to 47 nm) on different cell lines was examined. Three doses of IONPs, namely 1, 5 and 
25 µg Fe/ml, were tested. The span of studied IONPs doses in the literature is very wide. They range from single 
micrograms of Fe/ml18–22 to even milligrams of Fe/ml23–27. So, the doses studied by us belong rather to the lower 
ones analyzed in the context of IONPs toxicity. However, such doses correspond to those used in humans for 
medical diagnostics (contrast agents in MRI imaging) and those applied in patients for the treatment of iron 
deficiency  anemia28–30.
The present study were carried out on six cell lines and their careful choice was dictated by several factors 
described below. Since respiratory system is the most common path of penetration during the unintended 
exposure to NMs, human bronchial fibroblasts (NHLF) were  analyzed31–33. Kidneys constitute the most common 
removal route for different products of metabolism and foreign  bodies34–36, including IONPs, therefore human 
embryonic kidney HEK293T cells were selected for the study as well. To verify theranostic potential of the stud-
ied IONPs, their influence on human glioblastoma multiforme (GBM) cells lines U87MG and T98G as well as 
GBM cells KJT23I that were isolated from brain tumor of patient was  examined37–40. As NPs administered into 
circulatory system have been shown to accumulate within macrophages of mononuclear phagocyte system (MPS), 
present among others in liver and spleen, the mouse macrophages (MAC) were also included in the  study9,36.
To determine the influence of examined IONPs on cell survival two viability assays, namely MTT and trypan 
blue tests, were performed. It is necessary to mention that MTT test, evaluating the metabolic activity of cells, is 
the most commonly used measure of cytotoxicity in case of  IONPs41–44. Proliferation and migration activity of 
cells were also assessed in our study. Both parameters are utilized in the assessment of IONPs safety, however, 
much more rarely, comparing to different viability  assays45–48. According to the existing literature, one of the 
mechanisms of IONPs toxicity is oxidative  stress13,49–51. Therefore, we verifi d the level of oxidative stress induced 
by examined IONPs by quantifying and comparison of the intracellular ROS production in IONPs-treated and 
control cells.
In this paper for the fi st time (according to our best knowledge), the effect of IONPs on the cells was com-
pared with the appropriate data obtained for iron salts solutions containing the same amount of Fe, on similar 
oxidation state. Such comparison is necessary to answer the question if iron form is crucial for its influence on 
the living cells and whether Fe in the form of NPs is more/less safe compared to the free ions of this element.
Results
The assessment of the influence on cell proliferation. The changes in proliferation level of cells 
exposed to IONPs and iron salts solutions comparing to control group N are presented as box and whiskers 
charts in Fig. 1. Based on these experimental data, the growth rates and population doubling times were also 
calculated for each examined dose of Fe and the obtained results are placed in the Table 1.
Exposure to IONPs. As one can see from Fig.  1A no statistically signifi ant changes in proliferation were 
observed after 24, 48 and 72 h for HEK293T cells exposed to tested doses of IONPs. The macrophages mani-
fested signifi antly (p < 0.05) increased proliferation after 72 h from administration of 5 µg Fe/ml and 25 µg Fe/
ml IONPs solutions. For NHLF cell line the proliferation level diminished signifi antly after 24-h exposure to all 
applied doses of IONPs and was lower 72 h from administration of IONPs in concentrations of 1 µg Fe/ml and 
25 µg Fe/ml. In case of U87MG cell line, the proliferation activity was signifi antly lower 24 h after administra-
tion of IONPs solutions containing 1 µg Fe/ml and 5 µg Fe/ml. However, after 48-h exposure to IONPs in dose 
of 1 µg Fe/ml the U87MG proliferation increased. The proliferation level was also elevated in KJT23I cells after 
24 h from administration of 5 µg Fe/ml IONPs solution. In turn, after 72 h the KJT23I cells revealed signifi antly 
diminished proliferation as a result of the treatment with all IONPs doses used. The T98G cells manifested 
increased proliferation after 48-h exposure to 5 µg Fe/ml IONPs solution.
Exposure to iron salts solutions. After exposition of cells to solutions of Fe salts (Fig. 1B), we observed statisti-
cally signifi ant (p < 0.05) reduction of proliferation for HEK293T cells (24-h exposure to iron salts in concentra-
tions of 5 µg Fe/ml and 25 µg Fe/ml). In case of HEK293T cells treated with 25 µg Fe/ml the relevantly decreased 
level of proliferation persisted also after 48 and 72 h of exposition. The macrophages manifested signifi antly 
diminished proliferation, only after 24-h and 1 µg Fe/ml dose of iron in the form of salts solution. The prolif-
eration level of NHLF cells was signifi antly reduced 72 h from the administration of the iron salts solutions 
in concentrations of 5 µg Fe/ml and 25 µg Fe/ml. The proliferation of U87MG cell line was signifi antly lower 
comparing to the control group after 48 h for all iron doses used and after 72 h from administration of solution 
containing 25 µg Fe/ml. In case of KJT23I cells the proliferation was signifi antly diminished, only, after 72-h 
exposure to 25 µg Fe/ml iron salts solution. In turn T98G cell line manifested proliferation decrease after 24 h 
from administration of solutions containing 1 µg Fe/ml and 25 µg Fe/ml as well as after 48 and 72-h exposure 
to all applied iron doses.
The analysis of the data presented in Table 1 points that the solutions of Fe salts have negative impact on 
proliferation of most of the examined cell lines. The effect manifests itself in the increased population doubling 
time and the decreased growth rate. The IONPs impact on proliferation strongly depends on the type of cells and 
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maybe both negative, as for NHLF and KJT23TI cells and positive, as for macrophages, U87MG and T98G cells 
presenting decreased population doubling time either for some or all examined doses of IONPs.
The assessment of the influence on cell viability with trypan blue test. Exposure to IONPs. Th  
exposure of HEK293T cells to 1 µg Fe/ml IONPs solution resulted in statistically signifi ant (p < 0.05) diminish-
ing of their viability after 48 and 72 h. In turn the HEK293T cells treated with 5 µg Fe/ml and 25 µg Fe/ml IONPs 
solutions manifested diminished viability after 24, 48 and 72 h from administration. The other cell lines (MAC, 
NHLF, U87MG, KJT23I and T98G) demonstrated decreased viability level after 24, 48 and 72 h for all applied 
doses of IONPs. The decrease of observed viability is in the 1–5% range after 24-h, 1–8% range after 48-h and 
4–30% after 72-h exposures to IONPs (Fig. 2A).
Figure 1.  Cell number after 24, 48 and 72 h of exposure to IONPs (A) and iron salts solutions (B) in the 
concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml comparing to the control group (N). The statistically 
signifi ant (p < 0.05) increase in cell line proliferation level compared with corresponding N group was marked 
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Exposure to iron salts solutions. The exposure of HEK293T cells to 1 µg Fe/ml solution of iron salts resulted in 
statistically signifi ant (p < 0.05) reduction of their viability after 48 and 72 h. The HEK293T cells treated with the 
solutions containing 5 µg Fe/ml and 25 µg Fe/ml manifested diminished viability in all the examined periods of 
time. The other cell lines (MAC, NHLF, U87MG, KJT23I and T98G) demonstrated decreased viability level after 
24, 48 and 72 h for all applied doses of iron. As one can see from the Fig. 2B, the reduction of cells viability reach 
1–3% in case of 24 and 48-h exposure and is within the range of 1–4% for 72-h exposure.
The assessment of the influence on cell metabolic activity with MTT assay. Exposure to 
IONPs. In our experiments the metabolic activity of HEK293T cells was signifi antly diminished (p < 0.05) 
after 24-h exposure to IONPs solutions of 5 µg Fe/ml and 25 µg Fe/ml (Fig. 3A). In turn, in 48th h from the 
treatment with IONPs solution containing 25 µg Fe/ml, the MTT value for this cell line was elevated. The mac-
rophages revealed increased metabolic activity, only, after 24-h exposure to IONPs in concentration of 1 µg Fe/
ml. The signifi ant decrease in MTT values was observed for macrophages treated with IONPs solution con-
taining 25 µg Fe/ml after 48 and 72-h exposure. Metabolic activity of NHLF cells was found to be signifi antly 
diminished after 72-h exposure to IONPs solutions of 1 µg Fe/ml and 5 µg Fe/ml. The MTT value for U87MG 
cell line increased after 24-h treatment with IONPs solution in concentration of 25 µg Fe/ml. In case of KJT23I 
cells, the metabolic activity was elevated after 24-h exposure to IONPs solutions of 1, 5 and 25 µg Fe/ml. For 
the cells treated with IONPs in concentration of 25 µg Fe/ml, the MTT value diminished signifi antly after 48-h 
exposure. The metabolic activity of T98G cells decreased as a result of 24-h exposure to IONPs solutions of 5 µg 
Fe/ml and 25 µg Fe/ml and 72-h exposure to the concentration of 25 µg Fe/ml. In turn, after 72-h exposure to 
IONPs solution containing 1 µg Fe/ml, the MTT value for this cell line was signifi antly elevated.
Exposure to iron salts solutions. Exposition of HEK293T cells to solution of iron salts containing 25 µg Fe/ml 
(Fig. 3B) revealed their enhanced (p < 0.05) metabolic activity after 24-h exposure. In turn, in 72nd hour statisti-
cally relevant decrease in their metabolic activity was observed for all the examined doses of Fe. Macrophages 
exhibited elevated metabolic activity after 48 h following the treatment with the solution containing 25 µg Fe/ml. 
In case of NHLF cells, increased MTT values were found after 48-h exposure to iron salts solutions in concentra-
tions of 1 µg Fe/ml and 5 µg Fe/ml as well as after 72-h treatment with the dose of 5 µg Fe/ml. The U87MG cells 
metabolic activity was signifi antly elevated after 24-h exposure to iron solutions of 5 µg Fe/ml ad 25 µg Fe/ml as 
well as after 48-h treatment with all the three concentrations of Fe. 72-h exposure of U87MG cells to the doses of 
5 µg Fe/ml and 25 µg Fe/ml led to diminished MTT values. KJT23I cells revealed enhanced metabolic activity in 
Table 1.  The growth rates and population doubling times for examined cell lines exposed to IONPs and 
iron salts solutions as well as for corresponding control groups (N). a The number of doublings occurring per 
minute. b Calculated as ln(2)/growth rate.
Cell line Dose (µg/ml)
IONPs Fe salts
Growth  ratea  (min−1) Doubling  timeb (h) Growth rate  (min−1) Doubling time (h)
HEK293T
N 0.00062 18.8 0.00061 18.9
1 0.00062 18.5 0.00056 20.6
5 0.00066 17.6 0.00055 21.1
25 0.00060 19.4 0.00042 27.5
MAC
N 0.00057 20.4 0.00072 16
1 0.00063 18.4 0.00076 15.1
5 0.00064 18.1 0.00080 14.5
25 0.00065 17.7 0.00075 15.4
NHLF
N 0.00023 50.8 0.00020 58.8
1 0.00021 55.4 0.00018 63.2
5 0.00021 54.6 0.00011 110
25 0.00021 56.5 0.00002 664.2
U87MG
N 0.00019 59.8 0.00047 24.6
1 0.00023 50 0.00046 25.4
5 0.00020 58.8 0.00042 27.8
25 0.00022 52.3 0.00040 28.9
KJT23TI
N 0.00053 21.7 0.00026 45.1
1 0.00026 45.1 0.00023 51.1
5 0.00032 35.8 0.00025 46.9
25 0.00035 32.9 0.00021 56.3
T98G
N 0.00041 28.4 0.00041 28
1 0.00041 28.5 0.00018 63.7
5 0.00043 27 0.00008 141
25 0.00037 31.3 0.00004 288.3
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48th and 72nd hour from the treatment with iron salts solution of 25 µg Fe/ml. For T98G cells the MTT values 
were signifi antly elevated after 24-h exposure to the dose of 25 µg Fe/ml as well as after 48-h exposure to the 
doses of 1 µg Fe/ml and 5 µg Fe/ml. In 72nd hour in turn the signifi ant decrease in metabolic activity was found 
for T98G cells treated with solution of iron salts containing 1 µg Fe/ml.
The assessment of the influence on cell motility. The motility of cells was evaluated based on their 
speed and distance travelled (Figs. 4, 5). For this purpose time-lapse video microscopy was applied. To verify if 
Fe in the form of NPs or salts solutions modify the character of cellular movement, the coeffici ts of movement 
effici cy (CME—the ratio of cell displacement to cell trajectory length) were calculated and are presented in 
Fig. 6. The dot-plots depicting the displacement and the total length of trajectory (distance traveled) for single 
Figure 2.  Cell viability after 24, 48 and 72 h of exposure to IONPs (A) and iron salts solutions (B) in the 
concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml comparing to the control group (N). The statistically 
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cells together with the circular plots presenting trajectories of individual cells are, additionally, placed in the Sup-
plementary Information (Figures 2S–7S).
Exposure to IONPs. According to the results presented in Figs. 4A and 5A, in 24th hour after the administra-
tion of IONPs in dose of 25  µg Fe/ml the HEK293 cells speed and traveled distance decreased signifi antly 
(p < 0.05). In turn, the 48-h exposure of HEK293T cells to IONPs solutions in concentrations of 1 µg Fe/ml, 
5 µg Fe/ml and 25 µg Fe/ml resulted in signifi ant increase of the cellular motility. The macrophages exhibited 
enhanced motility after 24, 48 as well as 72 h exposure to each of IONPs concentrations tested. The speed and 
distance travelled by NHLF cells was found to be signifi antly elevated after 48-h exposure to each of IONPs 
concentration tested as well as after 72 h from application of IONPs in concentration of 5 µg Fe/ml. The motility 
of U87MG cells increased after 48-h of the exposure to IONPs solution of 1 µg Fe/ml. In turn, after 72 h from 
Figure 3.  Cell metabolic activity after 24, 48 and 72 h of exposure to IONPs (A) and iron salts solutions (B) 
in the concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml comparing to the control group (N). The 
statistically signifi ant (p < 0.05) increase of the metabolic activity compared with corresponding N group was 
marked with “#” while decrease with “*”.
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the treatment with the solution of 25 µg Fe/ml, the U87MG cells revealed signifi antly diminished speed and 
travelled distance. No statistically signifi ant changes in the motility were found for KJT23I cells. For T98G cells 
signifi ant increase of speed and distance travelled were observed after 24 h from the treatment with IONPs in 
concentration of 25 µg Fe/ml. After 48-h exposure to IONPs in concentration of 5 µg Fe/ml and 25 µg Fe/ml as 
well as after 72-h treatment with the solutions of 1 µg Fe/ml and 25 µg Fe/ml, the motility of T98G cells was also 
signifi antly elevated.
Exposure to iron salts solutions. In further experiments we investigated the impact of iron salt solutions on cell 
motile activity (Figs. 4B, 5B). The HEK293T cells exhibited signifi antly diminished (p < 0.05) motility after 24, 
48 and 72-h exposure to iron salts solution with the concentration of 25 µg Fe/ml. The distance travelled and 
speed of macrophages decreased after 24 and 48-h exposure to the solutions of 5 µg Fe/ml and 25 µg Fe/ml as 
Figure 4.  Cell speed after 24, 48 and 72 h of exposure to IONPs (A) and iron salts solutions (B) in the 
concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml comparing to control group (N). The statistically 
signifi ant (p < 0.05) increases in cell line motility level compared with corresponding N group were marked 
with “#” while decreases with “*”.
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well as after 72-h treatment with iron salts solution of 25 µg Fe/ml. In turn, after 48-h exposure to the solution of 
1 µg Fe/ml, the motility of macrophages was signifi antly elevated. The motility of NHLF cells was diminished 
after 48 and 72 h treatment with the solution of iron salts of 25 µg Fe/ml as well as after 72-h exposure to solution 
containing 1 µg Fe/ml. The speed and distance travelled of U87MG cells were found to be signifi antly decreased 
in 24th hour of the exposure 1 µg Fe/ml and 5 µg Fe/ml iron doses. For KJT23I cells, signifi ant increase of the 
motility was observed after 48-h exposure to iron salts solution containing 25 µg Fe/ml. The motility of T98G 
cells was signifi antly diminished after 24-h exposure to the solutions containing 25 µg Fe/ml as well as after 
48-h treatment with each of the tested iron concentrations. In turn, after 72-h exposure to iron salts in concen-
tration of 1 µg Fe/ml and 5 µg Fe/ml, the speed and distance travelled of T98G cells signifi antly elevated.
The analysis of the data presented in the Fig. 6 showed that 24-h long incubation of cells with IONPs did not 
change significantly the value of CME. Longer action of Fe in this form, either left the parameter unchanged or 
Figure 5.  Cell motility (speed and distance travelled) after 24, 48 and 72 h of exposure to iron salts solutions in 
the concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml comparing to control group (N). The statistically 
signifi ant (p < 0.05) increases of motility level compared with corresponding N group were marked with “#” 
while decreases with “*”.
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led to the decrease of CME. The iron salts solutions increased the effici cy of movement of T98G cells. What is 
more, for the highest dose of Fe in this form the effect was noticed for all the examined exposure times. Similar 
relation was found for NHLF cells after 72-h exposure to Fe salts. Reassuming, Fe in this form, more often than 
IONPs increased efficiency of cells movement.
The assessment of the influence on ROS production. The ROS activity was evaluated by qualitative 
(Figs. 7, 8) and quantitative (Fig. 9) assessment of the intracellular ROS probe fluorescence intensity. Changes 
in ROS production were determined by comparison of the results obtained for cells treated with IONPs or iron 
salts solutions with the ones recorded for corresponding control groups.
Figure 6.  CME coeffici t values after 24, 48 and 72 h of exposure to IONPs (A) and iron salts solutions (B) in 
the concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml comparing to control group (N). The statistically 
signifi ant (p < 0.05) increases of motility level compared with corresponding N group were marked with “#” 
while decreases with “*”.
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Exposure to IONPs. The IONPs induced anomalies in ROS production are clearly visible in fluorescence images 
presented in the Fig. 7 as well as in Fig. 9A containing the results of their quantitative analysis. Apparently, the 
signifi antly enhanced (p < 0.05) ROS activity was observed for HEK293T and U87MG cells after 24-h exposure 
to IONPs solutions containing 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml, as well as for T98G cells after the treat-
ment with the solution of 25 µg Fe/ml. The signifi antly diminished level of intracellular ROS was found after 
24-h treatment of macrophages and T98G cells with IONPs solution of 1 µg Fe/ml and for KJT23I cells exposed 
to IONPs in concentration of 5 µg Fe/ml. No statistically signifi ant changes in intracellular ROS level were 
observed in NHLF cells.
Exposure to iron salts solutions. As one can see from the Figs. 8 and 9B, the ROS activity in HEK293T cells was 
signifi antly elevated (p < 0.05) after 24-h exposure to iron salts solutions with concentrations 5 µg Fe/ml and 
25 µg Fe/ml. Enhanced intracellular level of ROS was also found for macrophages after 24-h of the exposure to 
the solutions containing 1 µg Fe/ml and 25 µg Fe/ml. NHLF cells demonstrated increased ROS activity after 24-h 
treatment with iron salts solution in concentration of 25 µg Fe/ml. In turn, for KJT23I cells signifi antly dimin-
ished intracellular ROS level was observed after 24-h exposure to the solution of 5 µg Fe/ml. No changes in the 
ROS activity were observed for U87MG and T98G cell lines treated with the iron salts solutions.
Discussion
Ultrasmall (with core size less than 10 nm) and ultrafine (with core size less than 5 nm) IONPs seem to be very 
promising group of IONPs taking into account their possible use in  medicine52. First, because of superparamag-
netic properties of such NPs, they have much less tendency to aggregate and  agglomerate53,54. They are also able 
to influence the T1-longitudinal relaxation time of tissues and can serve, in contrary to larger IONPs, as positive 
Figure 7.  Microscopic images presenting ROS levels after 24 h of exposure to IONPs in the concentrations of 
1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml compared with control group (N).
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Figure 8.  Microscopic images presenting ROS levels after 24 h of exposure to iron salts solutions in the 
concentrations of 1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml compared with control group (N).
Figure 9.  ROS levels after 24 h of exposure to IONPs (A) and iron salts solutions (B) in the concentrations of 
1 µg Fe/ml, 5 µg Fe/ml and 25 µg Fe/ml. The statistically signifi ant (p < 0.05) increases in ROS level compared 
with corresponding N group were marked with “#” while decreases with “*”.
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contrast agents in  MRI55,56. Because of smaller core size, their degradation time after internalization into cells of 
mononuclear phagocyte system is  shorter52. What is also important from the toxicological point of view, they 
can be faster excreted from the organism through the renal  clearance57.
IONPs are generally considered to be biocompatible, however, there is still a lot of controversies on this issue. 
They result from the fact that the toxicity of NPs very strongly depends on their size, shape, surface properties as 
well as the used  dose58. The first step of biocompatibility studies of any newly designed NPs are usually in vitro 
tests allowing to evaluate the influence of NPs on viability, proliferation, motility or ROS  generation59,60. In this 
aspect, a great effort should be done to choose the appropriate cellular lines for investigations, as the answer of 
different cells to the NPs action may significantly  differ61,62.
According to our best knowledge, this paper is the fi st regular in vitro study of the biocompatibility/toxicity 
of ultra-small IONPs. We examined the impact of NPs with 5 nm magnetite core on six different cellular lines 
important from the point of view of IONPs metabolism and their theranostic potential. The effect of IONPs on 
cells viability, proliferation, motility and ROS generation was examined at three doses of NPs and for three expo-
sure times. The analogue set of assays was implemented for the studies on solutions of iron salts containing the 
same amounts of Fe as in IONPs solutions and the proportions of  Fe2+ and  Fe3+ similar as in magnetite. Such an 
approach can help to answer the question if the form of Fe is crucial for its toxic influence on the studied cell lines.
Our investigation showed that the solutions of iron salts, depending on the used concentration and time of 
exposure, had a negative impact on cell proliferation. For the longest exposure time and the highest concentra-
tion of Fe, proliferation rate diminished for all examined cell lines, except macrophages. Contrary to iron salts, 
IONPs increased the proliferation rate for some of the examined cells. The effect was mainly observed for human 
GBM cell lines U87MG and T98G after 48-h treatment with IONPs and in KJT23I cells after 24-h exposure to 
IONPs. Similar result was found also for macrophages but after 72-h exposure. Thus IONPs, in contrary to Fe 
in the form of salts solutions may in some cases stimulate the cells proliferation. Th s observation indicate a 
potential negative impact of IONPs on the progression of GBM leading to faster tumor growth after MRI related 
IONPs use. The influence of IONPs on the proliferation of cells is not a commonly used measure of these NMs 
cytotoxicity. One of the examples of its use is the study of Abakumov MA et al., who verifi d the influence of 
IONPs coated with bovine serum albumin (BSA) as well as BSA‐coated and PEGylated on primary human 
fibroblasts and U251 human glioblastoma cell line. They found that BSA-coated and PEGylated IONPs had the 
less toxic influence on human fibroblasts and explained this effect by the protective action of PEG‐coating, which 
prevents the active uptake of NPs and delays their degradation and the release of iron  ions63. Functionalization 
of our NPs with PEG might have caused that their negative impact on cell proliferation was usually less than this 
observed for Fe salts. Such a conclusion, however, is not in agreement with our results concerning the effect of 
Fe in the two examined forms on cellular viability. Although, both Fe in the form of magnetite nanoparticles and 
solutions of the salts of the element had negative impact on the viability of cells, the effect was more prominent 
in case of IONPs and 72-h exposure of some cell lines to IONPs reduced the viability of cells even 20–30 percent 
comparing to the appropriate controls.
In our study we were focused on the relatively low doses of IONPs, however important from the point of 
view of NPs applications in humans for medical purposes. The doses varying from 1 to 25 µg Fe/ml correspond 
to clinical doses of IONPs-based contrast agents (lower) and drugs used for the treatment of iron deficie cy 
anemia (higher)28,29,64. According to the most of in vitro studies, for such IONPs doses the lack or low toxicity 
is  observed13,14,22,23. However, this is not the rule, as sometimes the cytotoxic effect is observed even at very low 
doses and short exposition  time20.
The MTT test of NADH—dependent enzymatic activity is, undoubtedly, the most frequently used assay 
of IONPs cytotoxicity  determination11,12,16. The existing literature shows that cytotoxic effect of IONPs on cell 
metabolic activity depends on the time of exposure and concentration of  NPs13,19. Our study revealed the lack 
of the influence of iron salts solutions on the measured with MTT test metabolic activity of macrophages. For 
all the other cell lines 24 and/or 48-h exposure to Fe in this form led to signifi ant increase of metabolic activity. 
After the next 24-h of the treatment, the effect persisted only for NHLF and KJT23I cells whilst the metabolic 
activity of HEK293T, U87MG and T98G cells decreased signifi antly comparing to the appropriate controls. The 
effect of IONPs on cell metabolic activity was observed mostly after 24-h exposure. 24-h treatment of U87MG 
and KJT23I cells as well as macrophages with IONPs increased their metabolic activity. The opposite relation 
was observed for HEK293T and T98G cells. The changes of metabolic activity were observed also after longer 
exposure to IONPs, however, the presence of any regularities was not found here. Unlike existing  studies20,23,65 
our research revealed that IONPs may stimulate cellular metabolism and such an effect was noticed after 24-h 
incubation for U87MG, KJT23I cells and macrophages. Although this observation may suggest a benefic al 
impact of the NPs on the enzymatic activity of macrophages, in case of tumor cell lines U87MG and KJT23I such 
an effect seem to be rather undesirable. Our studies also show that results obtained with MTT test do not often 
correlate with the results of proliferation measured by cell counting. So, using MTT test by many researchers as 
a proliferation test may lead to false conclusions.
In our studies IONPs, much more often than iron salts solutions, had positive impact on motility of cells which 
manifests in increased values of their speed and distance travelled. For macrophages and NHLF cells the effect 
was observed already after 24-h exposure to IONPs. For other examined cells the motility increased, mostly, after 
48-h treatment. The exposure of cells to iron in the form of salts of the element usually diminished the motility 
of the cells in dose-dependent manner and only few exceptions from this rule were found. Therefore, in the light 
of the obtained results, the influence of Fe on the parameters describing the motility of the cells strongly depend 
on the Fe form and it is usually positive in case of IONPs and negative in case of the iron salts solutions. These 
observation, together with the pro-proliferative effect of IONPs on GBM cells, may testify against using IONPs in 
GBM treatment. The increase of GBM cell motility after IONPs administration suggest the pro-invasive activity 
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of IONPs. Increased GBM cells invasiveness within brain tissue together with faster local tumor mass growth 
may lead to worse patients survival prognosis.
It should be emphasized that our observation, made for the cell lines treated with the PEG-coated IONPs, is 
quite unique since most of the papers report the cells motility impairment when exposed to  IONPs45–48. From the 
biokinetic point of view the colloidal sizes as well as concentrations of NPs tested in the aforementioned papers 
are comparable with those used in our  investigation9. Therefore, the observed discrepancies in the migration 
rate probably should be assigned to the differences in the core size of the examined IONPs. Moreover, accord-
ing to our results pointing on the potential of IONPs and Fe salts to generate oxidative stress in dose dependent 
manner, we hypothesize that the observed modulation of motility within some of examined cell lines may be 
result of induced disbalance within intracellular redox homeostasis. However, precise evaluation of mechanisms 
regulating such phenomenon requires much more extensive experimental approach.
The therapy using SPIONs can be carried out by using quite well-known phenomena such as magnetic 
hyperthermia, magnetic separation or targeted drug delivery. Recently, other possibilities of their application 
for therapeutic purposes are also being considered and one of them is associated with the exhibited by mag-
netite NPs, the catalytic activity analogous to  peroxidase66 . Magnetite, containing the iron on the second and 
third oxidation state, may be substrates to Fenton’s and Haber–Weiss reactions, respectively. In Haber–Weiss 
reaction,  Fe3+ ions are reduced into  Fe2+ ions which catalyze the Fenton’s reaction, leading to conversion of 
endogenous  H2O2 into a highly cytotoxic hydroxyl radical that can induce cancer cell  death67–69. Th s newly 
defined chemodynamic therapy is therefore based on the increased production of free radicals formed in the 
Fenton’s reaction. Therefore, one aspect of our research was evaluation of the impact of examined NPs on the 
intracellular production of free radicals in GBM cells and the comparison with analogous data obtained for 
cells important from the point of view of the exposure and metabolism of nanomaterials. IONPs increased ROS 
production in HEK293T and U87MG cells for all the examined doses of Fe, however, the evident enhancement 
of the effect together with the used dose of NPs was found only for the first mentioned cellular line. T98G cells 
presented dose dependent ROS levels—decreased for the lowest IONPs dose and elevated for the highest dose. 
For macrophages and KJT23I cell line, the level of ROS diminished as a result of exposure to NPs. The effect of Fe 
on HEK293T and KJT23I cells was almost independent on the form of the element in the solution and, similarly 
as for IONPs, the solutions of iron salts leaded to increased ROS activity in HEK293T cells and decreased activ-
ity in case of KJT23I cells. The opposite relation was found for macrophages for which the exposure to Fe salts 
solutions increased significantly ROS production. As one can see, the tested cells differ signifi antly in respect 
to the susceptibility to the treatment leading to the ROS overproduction. The observed differences, especially 
in case of tumor cells, may result from the mutations and epigenetic changes leading to the modifi ations in 
the expression of enzymes such as catalase or superoxide dismutase and in intracellular glutathione pool which 
are the main players in the regulation of ROS level. Their higher activity in exposed cells may quickly exclude 
ROS from the cytoplasm even when their production increase as a result of IONPs or Fe salts action. Different 
expression patterns of the oxidative stress-regulating enzymes may be one of the reason of diminished level of 
intracellular ROS in KJT23I cells exposed to IONPs and Fe salts. On the other hand, it is worth emphasizing that 
KJT23I cells grow in colonies which provide close intercellular communication and the possibility of collective 
response and attenuation of Fe induced cytotoxicity (by-stander effect)70. A quite worrying phenomenon is the 
strong effect of iron in both forms on ROS production in kidney HEK293T cells. As renal clearance is the main 
route for removing of nanomaterials and/or the products of their degradation from the body, such negative 
influence may point at the possibility of the organs damage after the treatment with IONPs. Such a conclusion 
seems to be in agreement with our previous studies in vivo, which showed that rat exposure to various IONPs 
may lead to significant elemental and biochemical anomalies within the  kidneys71,72.
conclusions
In this paper the first regular study of the biocompatibility of the ultra-small IONPs under in vitro conditions 
was presented. The obtained results were compared with data received for the solutions of Fe salts containing 
 Fe2+ and  Fe3+ in the proportions similar to magnetite being the core material of the examined NPs. The obtained 
results showed that Fe salts in higher doses diminished proliferation rate for most of the examined cell lines which 
was manifested by the decreased growth rates and increased doubling times of populations. In turn IONPs, for 
some doses and exposure times increased cell proliferation and this phenomenon was noticed for tumor cell 
lines (U87MG, T98G and KJT23I) and macrophages. In the light of our fi dings, both iron salts and IONPs 
diminished the viability of all examined cells. However, the effect was much more prominent for NPs. Further-
more, Fe in the form of salts solutions did not have any influence on metabolic activity of macrophages but, for 
some conditions, signifi antly increased the NADH – dependent enzymatic activity of other cell lines. IONPs 
influenced the metabolic activity of all examined cells and the effect strongly depended on the experimental 
conditions. What is more, IONPs very often improved the motility of cells, while the exposure to the Fe in the 
form of salts solutions usually diminished the speed and distance travelled by cells in time-dependent manner. 
Finally, both iron salts and IONPs affected the ROS activity of some examined cell lines. The exposure to Fe 
in the form of salts solutions enhanced ROS production in NHLF and HEK293T cells as well as macrophages 
but decreased the ROS level of KJT23I cell line. The treatment with IONPs increased ROS activity in HEK293T 
and U87MG cells, while in macrophages and KJT23I cells the diminished level of ROS was found as a result of 
their action. In turn, T98G cells exposed to IONPs revealed positive correlation between administered dose of 
NPs and ROS production. Reassuming, our results clearly suggest that the influence of iron on the living cells 
strongly depends not only to the used cellular line, dose and exposure time but also on the form in which this 
element was administered to the culture.
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Materials and methods
Cell lines. The cell lines selected for the study included primary human bronchial fibroblasts NHLF derived 
from bronchial biopsy, human embryonic kidney cells HEK293T (ATCC, CRL-3216), human GBM cell lines 
U87MG (ATCC, HTB-14), T98G (ATCC, CRL-1690) and KJT23I cells isolated from human brain tumor in the 
Clinic of Neurosurgery and Neurotraumatology of University Hospital in Bydgoszcz according to the consent of 
the Bioethics Commission for the use of cellular material collected from patients in neurooncological operations 
(Decision No. KB 535/2017 issued on 13.06.2017 by Bioethical Commission at University of Nicolaus Coperni-
cus in Toruń). Additionally, mouse P388D1 macrophages Mf (ATCC, CCL-46) were the subject of examination.
IONPs solution. Superparamagnetic iron (II,III) oxide nanoparticles (Sigma-Aldrich, 790508) with PEG 
coating and concentration of iron equal to 1 mg/ml were dispersed in distilled water. According to the informa-
tion provided by manufacturer the average nanoparticles size, assessed with transmission electron microscopy 
(TEM), was 5 nm. The hydrodynamic diameter of the particles as well as their Z-potential were measured with 
the use of dynamic light scattering (DLS) technique using Malvern Zetasizer Nano ZS instrument at the wave-
length of 532 nm. The diameter in the solution was estimated to 47.34 nm with the polydispersity index (PDI) 
of 0.408. In turn the Z-potential was equal to − 9.8 mV. The volume distribution of the hydrodynamic diameter 
for the examined nanoparticles was added to the Supplementary materials as a Figure 1S. Initial concentration 
of Fe in the IONPs solution was strictly determined by TXRF method using Rigaku Nanohunter II spectrometer 
and was equal to 897 (± 51) ppm. The IONPs stock solution was diluted to fi al iron concentrations of 1, 5 and 
25 µg/ml, that were applied to the selected cell lines.
Iron salts solution. Iron(III) sulfate hydrate (Sigma-Aldrich, F0638) and iron(II) sulfate heptahydrate 
(Sigma-Aldrich, F8633) were mixed in a 2:1 molar ratio in distilled water, respectively, to obtained proportions 
of Fe on the second and third oxidation state similar to those in magnetite. Iron salts solution was administered 
in concentrations corresponding to those of iron in the applied IONPs solutions, namely 1, 5 and 25 µg/ml.
Cell culture. Cells were cultured in 25 cm2 polystyrene culture flasks (Eppendorf) in DMEM medium with 
high glucose (4,500 mg/l) (Sigma-Aldrich), supplemented with 10% fetal bovine serum (Gibco) and 1% anti-
biotics: penicillin/streptomycin cocktail (Sigma-Aldrich). The cultures were grown under strictly controlled 
conditions: 5%  CO2, temperature 37 °C. The medium was changed every two days and the cells passaged when 
the confluence reached 80%. For that purpose the cells were washed with PBS without  Ca2+/Mg2+ (Corning), 
harvested with 0.25% Trypsin-EDTA solution (Gibco), resuspended in fresh medium, counted using Beckman 
Z2 particle counter and seeded into plastic culture dishes.
Cell proliferation and viability assays. Cells were seeded into 12-well culture plate at the density of 
2 × 104/cm2 and cultivated in DMEM medium. After 24 h, the culture medium was changed to fresh and the 
IONPs were administered at the three examined concentrations of iron, namely 1, 5 and 25  µg/ml. Culture 
medium without the IONPs was a control in each experiment. Cell proliferation analysis was performed using a 
Coulter Z2 Counter. After 24, 48 and 72 h from administration of IONPs, the cells were harvested and counted. 
In the next step doubling time and grow rate were calculated. In addition, all experiments were carried out for 
the iron salts solutions containing Fe at the concentration of 1, 5 and 25 µg/ml and in the appropriate proportion 
of  Fe2+ and  Fe3+.
Trypan blue was used for the determination of cells viability. The cells were passaged, centrifuged, resus-
pended in PBS and mixed with 0.4% trypan blue (Sigma-Aldrich) in ratio 1:1. After 2 min incubation, the cells 
were examined using a Bürker hemocytometer.
Cell metabolic activity was estimated with MTT assay. The cells were seeded into 96-well culture plate at the 
density of 5 × 103 per well and cultivated for 24 h before administration of Fe in the form of IONPs or solution 
of iron salts. After incubation for 24, 48, 72 h from administration of Fe in tested forms, 12 µl of MTT (Sigma-
Aldrich) solution was added to each well to a fi al concentration of 5 mg/ml and incubated at 37 °C for 4 h. The 
medium was removed carefully and 100 µl DMSO was added to each well and mixed until formazan crystals 
were dissolved. The absorbance of colored solution was measured using a plate reader (Multiskan FC Microplate 
Reader; Thermo Fisher Scientifi ) at the wavelength of 570 nm.
Cell motility. The cells were seeded into 12-well culture plate at the density of 2 × 104/cm2 and incubated in 
DMEM. After 24 h culture medium was replaced by DMEM with IONPs or solutions of iron salts at the exam-
ined concentrations of Fe. Cell movement was registered 24, 48 and 72 h after administration of tested forms 
of Fe, for 8 h with 5 min intervals using Leica DMI6000B microscope equipped with a IMC contrast optics, 
DFC360FX CCD camera and chamber allowing the control of  CO2 level and temperature. Average parameters 
of cell movement, namely average speed of cell movement (µm/min) and distance (µm) were quantifi d from 
the trajectories of 50 cells in each condition using Hiro program written by Czapla as described in the paper of 
Ryszawy et al.73.
ROS assay. Cells were seeded into 24-well imaging culture plate at the density of 2 × 104/cm2 and cultivated 
for 24 h before administration of IONPs (iron salts solutions). After 24, 48 and 72 h from administration of Fe 
in the form of IONPs or iron salts solutions, cells were incubated in the presence of CellROX Orange reagent 
(Invitrogen, C10443) at the concentration of 5 µM for 30 min at 37 °C. Afterwards, the reagent was replaced by 
FluoroBrite DMEM (Invitrogen, A1896702) containing 10% FBS and 4 mM GlutaMax (Invitrogen, 35050061). 
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Images were acquired with Leica DMI6000B fluorescence microscope and quantitative analysis of intracellular 
level of ROS was performed with ImageJ  software74,75.
Statistical analysis. The Mann–Whitney U-test was applied for statistical evaluation of changes in the cells 
proliferation, viability and ROS activity after exposure to each of the analyzed doses of Fe in the form of IONPs 
and iron salts. The choice of nonparametric statistical test was dictated by the fact that obtained data might not 
meet the assumptions concerning the normality, homoscedasticity and linearity which are necessary for use of 
parametric test. In turn, for assessing the signifi ance of observed changes in cell motility the parametric Stu-
dent’s t-test was applied. The differences between cells exposed to iron salts/IONPs solution and control group 
were analyzed at the signifi ance level of 5%. The statistical analysis was performed with StatSoft, Inc. (2005). 
STATISTICA (data analysis software system), version 7.1. www.stats oft.c m.
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